Trustmark National Bank Trust Department’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.04M | Sell |
33,856
-260
| -0.8% | -$54K | 0.48% | 46 |
|
|
2026
Q1 | $7.21M | Buy |
34,116
+2,251
| +7% | +$485K | 0.46% | 48 |
|
|
2025
Q4 | $6.55M | Buy |
31,865
+1,096
| +4% | +$206K | 0.41% | 56 |
|
|
2025
Q3 | $4.83M | Buy |
30,769
+1,028
| +3% | +$159K | 0.31% | 68 |
|
|
2025
Q2 | $5M | Buy |
29,741
+2,110
| +8% | +$313K | 0.35% | 65 |
|
|
2025
Q1 | $3.81M | Buy |
27,631
+4,150
| +18% | +$529K | 0.28% | 71 |
|
|
2024
Q4 | $2.78M | Buy |
23,481
+1,068
| +5% | +$125K | 0.21% | 90 |
|
|
2024
Q3 | $2.48M | Buy |
22,413
+279
| +1% | +$29.2K | 0.19% | 94 |
|
|
2024
Q2 | $2.18M | Sell |
22,134
-1,357
| -6% | -$138K | 0.17% | 100 |
|
|
2024
Q1 | $2.63M | Buy |
23,491
+1,159
| +5% | +$125K | 0.21% | 93 |
|
|
2023
Q4 | $2.25M | Buy |
22,332
+1,504
| +7% | +$149K | 0.2% | 94 |
|
|
2023
Q3 | $1.81M | Buy |
20,828
+3,888
| +23% | +$351K | 0.18% | 98 |
|
|
2023
Q2 | $1.6M | Buy |
16,940
+297
| +2% | +$25.1K | 0.15% | 114 |
|
|
2023
Q1 | $1.26M | Buy |
16,643
+8,986
| +117% | +$678K | 0.11% | 129 |
|
|
2022
Q4 | $589K | Buy |
7,657
+904
| +13% | +$68.7K | 0.05% | 172 |
|
|
2022
Q3 | $450K | Buy |
+6,753
| New | +$428K | 0.04% | 192 |
|
|
2016
Q4 | – | Sell |
-3,895
| Closed | -$303K | – | 250 |
|
|
2016
Q3 | $303K | Sell |
3,895
-327
| -8% | -$26.4K | 0.04% | 213 |
|
|
2016
Q2 | $330K | Sell |
4,222
-1,658
| -28% | -$132K | 0.04% | 217 |
|
|
2016
Q1 | $482K | Buy |
5,880
+659
| +13% | +$53.6K | 0.07% | 180 |
|
|
2015
Q4 | $466K | Buy |
5,221
+149
| +3% | +$12.7K | 0.06% | 200 |
|
|
2015
Q3 | $389K | Buy |
5,072
+190
| +4% | +$15.9K | 0.05% | 229 |
|
|
2015
Q2 | $409K | Sell |
4,882
-1
| -0% | -$88 | 0.05% | 228 |
|
|
2015
Q1 | $441K | Buy |
4,883
+892
| +22% | +$76.8K | 0.06% | 233 |
|
|
2014
Q4 | $322K | Sell |
3,991
-3,914
| -50% | -$309K | 0.04% | 246 |
|
|
2014
Q3 | $591K | Buy |
7,905
+11
| +0.1% | +$800 | 0.08% | 199 |
|
|
2014
Q2 | $541K | Sell |
7,894
-4,001
| -34% | -$272K | 0.06% | 214 |
|
|
2014
Q1 | $832K | Hold |
11,895
| – | – | 0.1% | 177 |
|
|
2013
Q4 | $794K | Buy |
11,895
+2,314
| +24% | +$141K | 0.09% | 171 |
|
|
2013
Q3 | $500K | Hold |
9,581
| – | – | 0.06% | 211 |
|
|
2013
Q2 | $452K | Buy |
+9,581
| New | +$438K | 0.06% | 215 |
|
Other funds holding CAH
Trustmark National Bank Trust Department's CAH Position: Q2 2026 in Review
Trustmark National Bank Trust Department reduced its Cardinal Health (CAH) stake by 0.76% in Q2 2026, selling an estimated $54K and leaving 33,856 shares worth $8.04M. The position accounts for 0.48% of the portfolio, ranked #46.
Trustmark National Bank Trust Department first reported a position in CAH in Q2 2013 and has held it in 30 quarters since. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Trustmark National Bank Trust Department held 33,856 shares of Cardinal Health worth $8.04M as of Q2 2026.
- Trustmark National Bank Trust Department sold 260 Cardinal Health shares in Q2 2026, an estimated $54K.
- Cardinal Health made up 0.48% of Trustmark National Bank Trust Department's portfolio in Q2 2026, its #46 holding.
- Trustmark National Bank Trust Department first reported a position in Cardinal Health in Q2 2013 and has held it in 30 quarters since.
- 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Trustmark National Bank Trust Department's 13F filing for Q2 2026, filed 12 Aug 2026.